Davis Bryce, Goux Warren J
The University of Texas at Dallas, Department of Chemistry, PO Box 830688, Richardson, TX 75083-0688, USA.
J AOAC Int. 2009 Nov-Dec;92(6):1607-16.
This report presents a single-laboratory-validated NMR method for determining the quantity of aloe vera polysaccharide in product formulations. The ratio of signal intensities of the acetyl methyl protons to methyl protons of an internal reference varied linearly with concentration (r2 > 0.99) with a lower LOQ of 0.2 g/100 mL for two commercial aloe polysaccharide standards, Acemannan Hydrogel (AH) and Immuno-10 (I-10). The assay was used to quantify these standards in two nonacetylated polysaccharide matrices, dextrin and arabinogalactan, and in a pharmaceutical product. The concentrations of AH in samples containing the polysaccharide matrices agreed within 7% of values determined on the basis of weight and showed within- and between-run RSD values of < 3.5%. The assay of I-10 in the pharmaceutical product was within 7% of the expected values over a range from 50 to 125% of the targeted I-10 concentration, with a between-run RSD of < 7%. The assay showed no interference from other added polysaccharides or from other components of the pharmaceutical formulation and was independent of the molecular size distribution of the aloe polysaccharide present. The NMR assay can be used to validate aloe polysaccharide contained in a product and to follow any chemical degradation that may occur over time.
本报告介绍了一种经单实验室验证的核磁共振方法,用于测定产品配方中芦荟多糖的含量。对于两种市售芦荟多糖标准品Acemannan Hydrogel(AH)和Immuno-10(I-10),乙酰甲基质子与内参甲基质子的信号强度比随浓度呈线性变化(r2>0.99),最低定量限为0.2 g/100 mL。该测定法用于在两种非乙酰化多糖基质(糊精和阿拉伯半乳聚糖)以及一种药品中对这些标准品进行定量。含有多糖基质的样品中AH的浓度与基于重量测定的值在7%以内相符,批内和批间相对标准偏差值<3.5%。在药品中I-10的测定值在目标I-10浓度的50%至125%范围内与预期值相差在7%以内,批间相对标准偏差<7%。该测定法未显示受到其他添加多糖或药品制剂其他成分的干扰,并且与存在的芦荟多糖的分子大小分布无关。核磁共振测定法可用于验证产品中所含芦荟多糖,并跟踪可能随时间发生的任何化学降解。